Zobrazeno 1 - 10
of 237
pro vyhledávání: '"Minoru, Ohta"'
Autor:
Yoshinori Kambayashi, Manabu Nemoto, Akihiro Ochi, Daiki Kishi, Takanori Ueno, Koji Tsujimura, Hiroshi Bannai, Nanako Kawanishi, Minoru Ohta, Tohru Suzuki
Publikováno v:
Veterinary Research, Vol 55, Iss 1, Pp 1-8 (2024)
Abstract In this study, equine intestinal enteroids (EIEs) were generated from the duodenum, jejunum, and ileum and inoculated with equine coronavirus (ECoV) to investigate their suitability as in vitro models with which to study ECoV infection. Immu
Externí odkaz:
https://doaj.org/article/01ab100aba244669a0733347cfc913f1
Autor:
Taisuke Kuroda, Yohei Minamijima, Christopher Ken Kinman, Yuji Takahashi, Yusaku Ebisuda, Kaori Inoue, Hiroshi Ishikawa, Hiroshi Mita, Norihisa Tamura, Toshio Nukada, Pierre-Louis Toutain, Minoru Ohta
Publikováno v:
Frontiers in Veterinary Science, Vol 11 (2024)
IntroductionQuinidine (QND) sulfate is an effective treatment for atrial fibrillation (AF) in horses, and several dosage regimens have been proposed to address its wide variability in response and potential adverse effects. The purpose of this study
Externí odkaz:
https://doaj.org/article/1d9fb92139a047028a031e47d59b22d7
Autor:
Taisuke KURODA, Yohei MINAMIJIMA, Hidekazu NIWA, Hiroshi MITA, Norihisa TAMURA, Kentaro FUKUDA, Pierre-Louis TOUTAIN, Minoru OHTA
Publikováno v:
Journal of Veterinary Medical Science; 2024, Vol. 86 Issue 4, p413-420, 8p
Autor:
Hiroshi Bannai, Koji Tsujimura, Manabu Nemoto, Minoru Ohta, Takashi Yamanaka, Hiroshi Kokado, Tomio Matsumura
Publikováno v:
BMC Veterinary Research, Vol 15, Iss 1, Pp 1-10 (2019)
Abstract Background Equine herpesvirus type 1 (EHV-1) infection is a major cause of pyrexias in winter among Japanese racehorses. In 2014–2015, the Japan Racing Association (JRA) changed the EHV-1 vaccine from an inactivated vaccine to a live vacci
Externí odkaz:
https://doaj.org/article/118f188071d94d808defdc5a92c8e3cf
Publikováno v:
Journal of Equine Science. 34:13-18
Autor:
Hirotaka Tokushige, Atsushi Okano, Daisuke Arima, Hideki Ito, Yoshinori Kambayashi, Yohei Minamijima, Minoru Ohta
Publikováno v:
Acta Veterinaria Scandinavica, Vol 60, Iss 1, Pp 1-8 (2018)
Abstract Background The aim of the present study was to evaluate clinical efficacy of constant rate infusions (CRIs) of medetomidine–propofol combined with sevoflurane anesthesia in Thoroughbred racehorses undergoing arthroscopic surgery. Thirty ho
Externí odkaz:
https://doaj.org/article/438ec347d2c24ab9b22ac1db7e980ec9
Autor:
Hirotaka Tokushige, Asuka Kushiro, Atsushi Okano, Tatsuya Maeda, Hideki Ito, Ai Wakuno, Shun-ichi Nagata, Minoru Ohta
Publikováno v:
Acta Veterinaria Scandinavica, Vol 60, Iss 1, Pp 1-7 (2018)
Abstract Background Alfaxalone has a number of pharmacological properties which are desirable for constant rate infusion (CRI). Previously, the co-administration of alfaxalone and medetomidine is shown to be suitable for short-term anesthesia in hors
Externí odkaz:
https://doaj.org/article/13021245e36642c5b0161a7ddf48a640
Autor:
Yoshinori Kambayashi, Daiki Kishi, Takanori Ueno, Minoru Ohta, Hiroshi Bannai, Koji Tsujimura, Yuta Kinoshita, Manabu Nemoto
Publikováno v:
Archives of Virology. 167:1611-1618
Equine coronavirus (ECoV) causes pyrexia, anorexia, lethargy, and sometimes diarrhoea. Infected horses excrete the virus in their faeces, and ECoV is also detected in nasal samples from febrile horses. However, details about ECoV infection sites in t
Publikováno v:
Archives of virology. 168(1)
The immune response and protective efficacy of a modified equid alphaherpesvirus 1 (EHV-1) vaccine administered by two different routes were tested in horses. Horses that received intramuscular (IM) priming and an intranasal (IN) booster with a 28-da
Autor:
Masataka Tominari, Hiroshi Bannai, Manabu Nemoto, Naoya Takebe, Yoshinori Kambayashi, Minoru Ohta, Tsuyoshi Nagashima, Koji Tsujimura
Publikováno v:
Journal of Equine Science
The antibody response in horses inoculated with 2 doses of a live equine herpesvirus type 1 vaccine with different vaccination intervals (1 to 3 months) was evaluated with regard to the persistence of virus-neutralizing (VN) antibodies. The durations